相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Si-Wei Wang et al.
MOLECULAR CANCER (2022)
Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity
Wencheng Wu et al.
NANO TODAY (2022)
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy
Di Zhang et al.
NATURE NANOTECHNOLOGY (2022)
A Cancer Cell Membrane-Derived Biomimetic Nanocarrier for Synergistic Photothermal/Gene Therapy by Efficient Delivery of CRISPR/Cas9 and Gold Nanorods
Lin Huang et al.
ADVANCED HEALTHCARE MATERIALS (2022)
A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders
Xiaojie Xu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Sonodynamic therapy-derived multimodal synergistic cancer therapy
Mimi Xu et al.
CANCER LETTERS (2021)
Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway
Nathan Harmston et al.
CANCER RESEARCH (2021)
Oxygen self-sufficient photodynamic therapy
Fangmian Wei et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy
Xiangyu Deng et al.
ADVANCED SCIENCE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy
Tao Wan et al.
NANO LETTERS (2021)
Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
Haohao Yin et al.
ACS CENTRAL SCIENCE (2021)
Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy
Haitao Sun et al.
NANO TODAY (2021)
Programmable Unlocking Nano-Matryoshka-CRISPR Precisely Reverses Immunosuppression to Unleash Cascade Amplified Adaptive Immune Response
Jin Yang et al.
ADVANCED SCIENCE (2021)
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment q
Xiaoyu Xu et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
CRISPR/Cas9-2D Silicene Gene-Editing Nanosystem for Remote NIR-II-Induced Tumor Microenvironment Reprogramming and Augmented Photonic Tumor Ablation
Haohao Yin et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Sono-Controllable and ROS-Sensitive CRISPR-Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy
Yinying Pu et al.
ADVANCED MATERIALS (2021)
Hypoxia-Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild-Photothermal Therapy
Xueqing Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Controlled CRISPR-Cas9 Ribonucleoprotein Delivery for Sensitized Photothermal Therapy
Chao Chen et al.
SMALL (2021)
Reduction-Sensitive Fluorinated-Pt(IV) Universal Transfection Nanoplatform Facilitating CT45-Targeted CRISPR/dCas9 Activation for Synergistic and Individualized Treatment of Ovarian Cancer
Hongtong Lu et al.
SMALL (2021)
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Lauren Giuffrida et al.
NATURE COMMUNICATIONS (2021)
Advanced biotechnology-assisted precise sonodynamic therapy
Yi Zhang et al.
CHEMICAL SOCIETY REVIEWS (2021)
Spatiotemporal control of CRISPR/Cas9 gene editing
Chenya Zhuo et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Chain-shattering Pt(IV)-backboned polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic cancer therapy
Qingfei Zhang et al.
NANO RESEARCH (2021)
A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer
Chao Liu et al.
THERANOSTICS (2021)
Two-Dimensional Nanomaterials for Photothermal Therapy
Shuang Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
Genomic basis for RNA alterations in cancer
Claudia Calabrese et al.
NATURE (2020)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing
Xiaohong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death
Kun Tu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification
Wencheng Wu et al.
ADVANCED MATERIALS (2020)
Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression
Xiao-Yan He et al.
ADVANCED MATERIALS (2020)
Cancer burden of major cancers in China: A need for sustainable actions
Maomao Cao et al.
CANCER COMMUNICATIONS (2020)
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
Meghan A. Morrissey et al.
IMMUNITY (2020)
Multistage Sensitive NanoCRISPR Enable Efficient Intracellular Disruption of Immune Checkpoints for Robust Innate and Adaptive Immune Coactivation
Ning Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy
Shuang Liang et al.
ADVANCED MATERIALS (2020)
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Hossein Rahimi et al.
NANO TODAY (2020)
Targeting the Wnt/β-catenin signaling pathway in cancer
Ya Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Photo-Enhanced CRISPR/Cas9 System Enables Robust PD-L1 Gene Disruption in Cancer Cells and Cancer Stem-Like Cells for Efficient Cancer Immunotherapy
Liang Zhao et al.
SMALL (2020)
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
Dan Sha et al.
CANCER DISCOVERY (2020)
Fighting Immune Cold and Reprogramming Immunosuppressive Tumor Microenvironment with Red Blood Cell Membrane-Camouflaged Nanobullets
Zhe Yang et al.
ACS NANO (2020)
A compendium of mutational cancer driver genes
Francisco Martinez-Jimenez et al.
NATURE REVIEWS CANCER (2020)
Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers
Timothy R. Wilson et al.
MOLECULAR CANCER RESEARCH (2019)
Radiotherapy toxicity
Dirk De Ruysscher et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams et al.
JAMA ONCOLOGY (2019)
Immunogenic cell death in cancer therapy: Present and emerging inducers
Jingyi Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition
Wencheng Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
The Sly Oncogene: FOXA1 Mutations in Prostate Cancer
Neel Shah et al.
CANCER CELL (2019)
A dynamic view of chemotherapy
Yunpeng Liu et al.
NATURE (2019)
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
Martin W. LaFleur et al.
NATURE IMMUNOLOGY (2019)
Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
K. M. Heinhuis et al.
ANNALS OF ONCOLOGY (2019)
Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer
Tala M. Abu Samaan et al.
BIOMOLECULES (2019)
HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma
Cheuk-Ting Law et al.
HEPATOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo
Qi Liu et al.
ADVANCED SCIENCE (2019)
Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy
Lian-Hua Fu et al.
ADVANCED MATERIALS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Photodynamic therapy - mechanisms, photosensitizers and combinations
Stanislaw Kwiatkowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi et al.
CANCER CELL (2018)
Organic molecule-based photothermal agents: an expanding photothermal therapy universe
Hyo Sung Jung et al.
CHEMICAL SOCIETY REVIEWS (2018)
The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
Yu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
IMMUNOTHERAPY Cancer immunotherapy and the value of cure
Joseph C. Del Paggio
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Paclitaxel and Pazopanib in Ovarian Cancer
Federica Tomao et al.
JAMA ONCOLOGY (2018)
CRISPR-Cas guides the future of genetic engineering
Gavin J. Knott et al.
SCIENCE (2018)
Applications of CRISPR-Cas9 Technology in Translational Research on Solid-Tumor Cancers
Patricia Chen et al.
CRISPR JOURNAL (2018)
Modulating DNA Repair Pathways to Improve Precision Genome Engineering
Katherine S. Pawelczak et al.
ACS CHEMICAL BIOLOGY (2018)
Interaction between Wnt/beta-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of beta-catenin and RAS by targeting the Wnt/beta-catenin pathway
Woo-Jeong Jeong et al.
NPJ PRECISION ONCOLOGY (2018)
Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice
Ling Li et al.
ACS NANO (2017)
Type II CRISPR/Cas9 approach in the oncological therapy
A. Biagioni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3
Lai Wei et al.
JOURNAL OF HEPATOLOGY (2017)
Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study
Miranda M. Fidler et al.
LANCET ONCOLOGY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Nanoparticles for CRISPR-Cas9 delivery
Zachary Glass et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan et al.
CHEMICAL REVIEWS (2017)
Photodynamic Therapy: Past, Present and Future
Ushasri Chilakamarthi et al.
CHEMICAL RECORD (2017)
Mutational Signatures in Breast Cancer: The Problem at the DNA Level
Serena Nik-Zainal et al.
CLINICAL CANCER RESEARCH (2017)
Cancer immunotherapies targeting the PD-1 signaling pathway
Yoshiko Iwai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation
Antonia A. Dominguez et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
Micro/Nanoparticle-Augmented Sonodynamic Therapy (SDT): Breaking the Depth Shallow of Photoactivation
Xiaoqin Qian et al.
ADVANCED MATERIALS (2016)
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma
Tai Hato et al.
IMMUNOTHERAPY (2016)
Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy
Hao Zhou et al.
NANO LETTERS (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
R. Dixon Dorand et al.
SCIENCE (2016)
HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy
Tzu-yin Lin et al.
THERANOSTICS (2016)
Multifunctional WS2@Poly(ethylene imine) Nanoplatforms for Imaging Guided Gene-Photothermal Synergistic Therapy of Cancer
Chunfang Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2016)
CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems
Wenyan Jiang et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)
CRISPR-Cas9: a new and promising player in gene therapy
Lu Xiao-Jie et al.
JOURNAL OF MEDICAL GENETICS (2015)
Inducible in vivo genome editing with CRISPR-Cas9
Lukas E. Dow et al.
NATURE BIOTECHNOLOGY (2015)
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Junwei Shi et al.
NATURE BIOTECHNOLOGY (2015)
Personalized genomic analyses for cancer mutation discovery and interpretation
Sian Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
Applications of the CRISPR-Cas9 system in cancer biology
Francisco J. Sanchez-Rivera et al.
NATURE REVIEWS CANCER (2015)
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Luke A. Gilbert et al.
CELL (2014)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Cellular Levels of 8-Oxoguanine in either DNA or the Nucleotide Pool Play Pivotal Roles in Carcinogenesis and Survival of Cancer Cells
Yusaku Nakabeppu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Unravelling the structural and mechanistic basis of CRISPR-Cas systems
John van der Oost et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Classification and evolution of type II CRISPR-Cas systems
Krzysztof Chylinski et al.
NUCLEIC ACIDS RESEARCH (2014)
Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors
Todd M. Pitts et al.
PHARMACOLOGY & THERAPEUTICS (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
Recent advances in delivery of drug-nucleic acid combinations for cancer treatment
Jing Li et al.
JOURNAL OF CONTROLLED RELEASE (2013)
INNOVATION TALENs: a widely applicable technology for targeted genome editing
J. Keith Joung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Giedrius Gasiunas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Programmed cell removal: a new obstacle in the road to developing cancer
Mark P. Chao et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeted Genome Editing Across Species Using ZFNs and TALENs
Andrew J. Wood et al.
SCIENCE (2011)
Self versus non-self discrimination during CRISPR RNA-directed immunity
Luciano A. Marraffini et al.
NATURE (2010)
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov et al.
NATURE REVIEWS GENETICS (2010)
A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination
Dong-Hyun Lee et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
EPIGENETIC CHANGES IN TUMOR SUPPRESSOR GENES, P15, P16, APC-3 AND E-CADHERIN IN BODY FLUID
Mei-Ling Chen et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2007)
Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1
Chi-Chung Wang et al.
CANCER RESEARCH (2007)
From molecular biology to targeted therapies for hepatocellular carcinoma: The future is now
Roberta W. C. Pang et al.
ONCOLOGY (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Targeted cancer nanotherapy
Gloria J. Kim et al.
MATERIALS TODAY (2005)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study
M Brink et al.
CARCINOGENESIS (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
DC Chung
GASTROENTEROLOGY (2000)